Weilin Xie
- Molecular Biology
- Oncology top 10%
- Cell Biology top 10%
- Hematology top 10%
- Immunology
- Co-authors
- Frank MercurioYou-Wei ZhangGary G. ChiangRobert T. AbrahamDiane M. OtternessYun‐Cai LiuLaura G. CorralAntonia Lopez‐Girona
- Topics
- Ubiquitin and proteasome pathways (4 papers)Glycosylation and Glycoproteins Research (3 papers)Chronic Lymphocytic Leukemia Research (2 papers)
- Cited by
- OncologyMolecular BiologyHematology
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Weilin Xie
14 papers receiving 825 citations
Hit Papers
Peers
Comparison fields: 5 of 67
- Molecular Biology 674
- Oncology 304
- Cell Biology 127
- Hematology 98
- Immunology 83
Countries citing papers authored by Weilin Xie
This map shows the geographic impact of Weilin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilin Xie more than expected).
Fields of papers citing papers by Weilin Xie
This network shows the impact of papers produced by Weilin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilin Xie. The network helps show where Weilin Xie may publish in the future.
Co-authorship network of co-authors of Weilin Xie
This figure shows the co-authorship network connecting the top 25 collaborators of Weilin Xie. A scholar is included among the top collaborators of Weilin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilin Xie. Weilin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Targeted protein degradation: advances in drug discovery and clinical practicebreakdown → | 82 |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 6 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | Diosgenin attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway. | 17 |
| 8 | 55 | |
| 9 | Gastromegaly infiltrated with plasma cells: a new feature of organomegaly in patients with POEMS syndrome. | 1 |
| 10 | 9 | |
| 11 | 75 | |
| 12 | 3 | |
| 13 | 220 | |
| 14 | 21 | |
| 15 | 235 | |
| 16 | 101 |
About Weilin Xie
Weilin Xie is a scholar working on Genetics, Hematology and Immunology and Allergy, having authored 16 papers that have together received 836 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Glycosylation and Glycoproteins Research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Oncology (304 citations), Molecular Biology (674 citations) and Hematology (98 citations). Weilin Xie has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Frank Mercurio, You-Wei Zhang, Gary G. Chiang, Robert T. Abraham, Diane M. Otterness, Yun‐Cai Liu, Laura G. Corral, Antonia Lopez‐Girona, Xiangxiang Zhou and David R. Webb. Their work appears in journals such as Blood, Molecular Cell and Journal of Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.